AMREP Co. (NYSE:AXR – Get Rating) Director Edward B. Cloues II acquired 2,500 shares of AMREP stock in a transaction on Tuesday, April 19th. The shares were purchased at an average cost of $12.53 per share, with a total value of $31,325.00. Following the completion of the acquisition, the director now owns 23,865 shares of the company’s stock, valued at approximately $299,028.45. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Shares of NYSE:AXR traded up $0.27 during trading on Wednesday, hitting $12.60. 3,339 shares of the company were exchanged, compared to its average volume of 18,157. The company has a market cap of $92.43 million, a PE ratio of 9.48 and a beta of 0.78. The stock has a 50 day moving average of $12.20 and a 200 day moving average of $13.77. AMREP Co. has a 52-week low of $9.76 and a 52-week high of $18.80.
AMREP (NYSE:AXR – Get Rating) last issued its quarterly earnings data on Thursday, March 10th. The business services provider reported $0.12 earnings per share (EPS) for the quarter. AMREP had a return on equity of 10.60% and a net margin of 17.69%. The company had revenue of $9.82 million for the quarter.
AMREP Company Profile (Get Rating)
AMREP Corporation, through its subsidiaries, primarily engages in the real estate business. It operates through two segments, Land Development and Homebuilding. The company sells developed and undeveloped lots to homebuilders, commercial and industrial property developers, and others. As of July 1, 2021, it owned approximately 18,000 acres in Rio Rancho, New Mexico.
Featured Stories
- Get a free copy of the StockNews.com research report on AMREP (AXR)
- Highly Valued Abbot Laboratories Could Move Lower
- Baker Hughes, Another Buy-The-Dip Opportunity In Oilfield Services
- Netflix (NASDAQ: NFLX) Falls Back to 2018 Levels
- Is Turning Point Therapeutics Stock at a Turning Point?
- Buy Haliburton On Post-Earnings Weakness
Receive News & Ratings for AMREP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMREP and related companies with MarketBeat.com's FREE daily email newsletter.